|
|
Article: Chemokine Therapeutics announces addition to senior management team.
- Article from:
- PR Newswire
- Article date:
- March 22, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
TSX: CTI OTCBB: CHKT
VANCOUVER, March 22 /PRNewswire-FirstCall/ -- Chemokine Therapeutics Corp. ("Chemokine Therapeutics" or the "Company") (TSX:CTI, OTCBB:CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular disease today announced the appointment of C. Richard Piazza as its new Chief Executive Officer (CEO). Mr. Piazza succeeds Dr. Hassan Salari who held the position since he founded the Company in 1998. Dr. Salari will continue to serve the Company as President and his role will be expanded to include the additional responsibilities as the Chief Scientific Officer. These changes will allow Dr. ...